All Pharma News
Neurocrine launches CAH rare disease education campaign ahead of FDA submission

Neurocrine launches CAH rare disease education campaign ahead of FDA submission
ENDPTS
24 Apr 2024
Share Share
Neurocrine scores surprise win with depression drug

Neurocrine scores surprise win with depression drug
Https://www.biopharmadive.com/news/neurocrine-depression-study-medicine-takeda-results/714001/ BIOPHARAMDIVE
24 Apr 2024
Share Share
Neurocrine Reports Positive Phase 2 Data for NBI-1065845 in Depression

Neurocrine Reports Positive Phase 2 Data for NBI-1065845 in Depression
PR NEWSWIRE
23 Apr 2024
Share Share
Voyager Selects GBA1 Program Candidate, Triggers Milestone with Neurocrine

Voyager Selects GBA1 Program Candidate, Triggers Milestone with Neurocrine
GLOBENEWSWIRE
16 Apr 2024
Share Share
Sentia and Neurocrine Extend Collaboration to Discover Novel CRF Peptides

Sentia and Neurocrine Extend Collaboration to Discover Novel CRF Peptides
GLOBENEWSWIRE
16 Apr 2024
Share Share
Nxera Pharma Notes Successful Progress of Schizophrenia Candidate NBI-1117568

Nxera Pharma Notes Successful Progress of Schizophrenia Candidate NBI-1117568
GLOBENEWSWIRE
16 Apr 2024
Share Share
Neurocrine Biosciences Schedules Q1 2024 Financial Results Call

Neurocrine Biosciences Schedules Q1 2024 Financial Results Call
PR NEWSWIRE
10 Apr 2024
Share Share
Neurocrine Announces First Dosed in Ph 2 Study Evaluating NBI-1070770

Neurocrine Announces First Dosed in Ph 2 Study Evaluating NBI-1070770
PR NEWSWIRE
03 Apr 2024
Share Share
Endometriosis Global Clinical Trials Review 2024

Endometriosis Global Clinical Trials Review 2024
BUSINESSWIRE
02 Apr 2024
Share Share
Neurocrine Announces Initiation of Ph1 Study Evaluating NBI-1065890

Neurocrine Announces Initiation of Ph1 Study Evaluating NBI-1065890
PR NEWSWIRE
28 Mar 2024
Share Share